Navigation Links
ProAssurance Receives Regulatory Approvals for Transactions with the PICA Group and Georgia Lawyers Insurance Company
Date:1/28/2009

rance agents through its PACO subsidiary.

Update on the Mid-Continent and Georgia Lawyers Transactions

ProAssurance also announced the completion of its acquisition of Mid-Continent General Agency, a Houston-based Managing General Agent which produces about $25 million a year in premiums from ancillary healthcare providers and other professional liability coverages.

Starnes was equally enthusiastic about the opportunities ahead with Mid-Continent. He said, "We expect Mid-Continent to help us develop a deeper presence in the professional liability market for ancillary healthcare providers, a segment of the healthcare industry that is expected to undergo a rapid expansion in most healthcare reform scenarios."

ProAssurance also said regulatory approval has been granted to allow its acquisition of the Georgia Lawyers Insurance Company (GLIC). Shareholders of GLIC have already approved the transaction, which is expected to close during the first week of February. GLIC insures approximately 2,700 lawyers in Georgia and had direct written premium of approximately $5.5 million in 2007.

About ProAssurance

ProAssurance Corporation is the nation's fifth largest writer of medical professional liability insurance and is growing its legal professional liability business. ProAssurance is recognized as one of the top performing insurance companies in America by virtue of its inclusion in the Ward's 50 for the past two years.


'/>"/>
SOURCE ProAssurance Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ProAssurance Acquires Mid-Continent General Agency to Expand Ancillary Healthcare Insurance Business
2. ProAssurance to Present at Oppenheimer Investor Conference
3. The PICA Group Will Become Part of ProAssurance
4. ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan
5. PEAK Surgical Receives European CE Mark for PEAK(R) Surgery System for Use in General Surgery
6. Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
7. UTSA receives federal funding for fossil fuel research
8. ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica
9. UTSA receives $1.2 million gift from Kleberg Foundation
10. IPC The Hospitalist Company Receives Best IPO Award from Los Angeles Venture Association
11. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--A...terforDrugEvaluationandResearch,titled"ADifficultB...sintheNov.26,2009issueofTheNewEnglandJournalofMedi...prnh/20090824/FDALOGO ) ,, Inthearticle,Woodcoc...opainmedicationforthosewhoneeditandmanagingtherisk...
(Date:11/25/2009)...rchers have found evidence of a statistically sign...mong patients whose estrogen receptor (ER)-positiv...alpha; at serine-118 (ER-alpha S118-P), according ... 25 in the Journal of the National Cancer Institu...e resistant to tamoxifen. Preclinical studies have...
(Date:11/25/2009)... Evaluation and treatment clinic... Woodstock (Vocus) November 25, 2009 -- Centeg... vaccines and H1N1 vaccine shots at four Centegra ...er shipment of vaccine has arrived. The clinics ar... and McHenry and will be open as follows: , &n...
(Date:11/25/2009)... ARLINGTON,Va.,Nov.25/PRNewswire-USNewswire/--TheA...tHealthCareFraudActof2009,"S.2128,whichisdesignedt...reventfraudinMedicare.ThebillwasintroducedbySen.Ge...everalprovisionstheAmericanAssociationforHomecareo...ssociationproposedtoCongressinFebruary.Thoseprovis...
(Date:11/25/2009)..., disks placed under the skin kill tumor cells, st...Day News) -- A cancer vaccine delivered in a finge...ice, a new study reports. , The method uses pol...loaded with tumor-specific antigens and implanted ...ttack tumors. The Harvard University scientists wh...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...AGO, Aug. 16, 2007 One in three people exposed to...TMJ symptoms that may require treatment, according...Journal of the American Dental Association. , Res...cy rooms directly after they were involved in a re...
...ESTER, Minn. -- A team of Mayo Clinic researchers ...t to detect infection of prosthetic joints, potent...ent outcomes. , The new method, which samples bac... joints removed for infection or another cause. Th...
...dren who are chronically exposed to higher levels ...growth and function, and not just short-term breat... , "Our study revealed significant deficits in lu...to the important impact of lung health, early lung...
...st cancer preventive practices for Canadian women ...says University of Toronto research, and many wome...e. , The study, published in the journal Open Med...isk of developing breast cancer. Women carrying th...
...viduals with diabetes and acute coronary syndromes...ave an increased risk of death at 30 days and one ... diabetes, according to a study in the August 15 i...rldwide each year. With the increase in obesity, i...
...mply giving parents informational handouts can imp...d risk of cancer related to pediatric CT, accordin...The Childrens Hospital in Denver, CO and Yale Univ...osure to children caused by increased usage of CT....
Other Medicine News:Health News:Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints 2Health News:Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints 3Health News:High pollution linked to poor lung function growth in children in Mexico City 2Health News:Breast cancer prevention practices vary across Canada 2Health News:Diabetes appears to increase risk of death for patients with acute coronary syndromes 2Health News:Informational handout key to giving parents a better understanding of CT radiation risks 2
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
(Date:11/25/2009)...RNewswire/--Reportlinker.comannouncesthatanewmarke...ntranasalDrugDelivery-USMarketTrends&Analysis ...rug-Delivery---US-Market-Trends--Analysis.html ,...nexpansionoftherapeuticapplicationsfromthedelivery...systemictherapeuticdrugs.Thefutureofthetechnologyh...
(Date:11/25/2009)...andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareI...nnovatorandprovideroflessinvasive,miniaturizedcirc...entofadvancedheartfailure,todayannouncedthatitissc...PiperJaffrayHealthCareConferenceat8:00amESTonWedne...ewYorkPalaceHotel,December1-2. ,, Alivewebcasto...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Nordic Omega 3 Fishies from Nordic Naturals Offers Quality EPA and DHA for Children with Kid Pleasin Taste 49714 1Nordic Omega 3 Fishies from Nordic Naturals Offers Quality EPA and DHA for Children with Kid Pleasin Taste 49714 2AFFiRiS AG 3A 1st Place in Venture Capital 26 Private Equity Awards for MIG Fonds and AFFiRiS 12736 1AFFiRiS AG 3A 1st Place in Venture Capital 26 Private Equity Awards for MIG Fonds and AFFiRiS 12736 2AFFiRiS AG 3A 1st Place in Venture Capital 26 Private Equity Awards for MIG Fonds and AFFiRiS 12736 3Transforming the HR Function Into Strategic Partner at World 26apos 3Bs Largest Medical Device Company 49707 1Transforming the HR Function Into Strategic Partner at World 26apos 3Bs Largest Medical Device Company 49707 2
...nted at Federation of,Clinical Immunology Societie... 11, 2007 /PRNewswire-FirstCall/ --,Orchestra Ther...day,positive new data from its completed Phase II ...al T Cell Receptor (TCR) peptide,vaccine for the t...,(MS). The new data, presented last week at the Fe...
...wswire/ -- NovaCardia, Inc.,today presented prelim...2, an adenosine A1 receptor antagonist in developm...stive heart failure (CHF),that indicate a strong ...atients treated with KW-3902 experienced a higher ...eath, which is a common,symptom of CHF, compared t...
Other Medicine Technology:Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 2Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 3Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 4
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: